Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Excelsior Biopharma Inc (6496) Income Statement

Excelsior Biopharma Inc Income Statement

Last quarter (Q2 2026), Excelsior Biopharma Inc's total revenue was NT$232.49M, an increase of 15.10% from the same quarter last year. In Q2, Excelsior Biopharma Inc's net income was NT$-57.46M. See Excelsior Biopharma Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 898.26MNT$ 861.91MNT$ 771.56MNT$ 671.76MNT$ 1.34B
NT$ 360.17MNT$ 382.10MNT$ 306.93MNT$ 287.17MNT$ 293.35M
NT$ 534.33MNT$ 460.82MNT$ 388.06MNT$ 320.13MNT$ 297.65M
Depreciation and AmortizationNT$ 71.68MNT$ 70.96MNT$ 46.22MNT$ 26.06MNT$ 28.65M
NT$ -92.90MNT$ -8.40MNT$ -29.37MNT$ 4.41MNT$ 23.16M
NT$ -174.16MNT$ -78.73MNT$ -81.13MNT$ -25.32MNT$ -1.02M
NT$ 1.82MNT$ -8.66MNT$ -823.00KNT$ 3.30MNT$ -1.26M
NT$ -172.34MNT$ -87.39MNT$ -81.95MNT$ -25.99MNT$ -10.03M
NT$ -183.17MNT$ -98.70MNT$ -91.01MNT$ -33.76MNT$ -15.65M
Per Share Metrics
Basic EPSNT$ -3.97NT$ -2.14NT$ -1.98NT$ -0.72NT$ -0.34
Diluted EPSNT$ -3.97NT$ -2.14NT$ -1.98NT$ -0.71NT$ -0.34
Weighted Average Shares Outstanding46.14M46.11M45.92M46.67M46.51M
Weighted Average Shares Outstanding (Diluted)46.14M46.11M45.92M47.51M46.51M

Currency in TWD

Excelsior Biopharma Inc Earnings and Revenue History

-800M0800M1.6B-24 %-12 %0 %12 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin